Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |